Clin2
NCT07720271Possibly a fitRecruiting

Zenagamtide weight loss study for adults

OverweightObesity

Part of Hormones & metabolism clinical trials.

This study is testing a new tablet called Zenagamtide to help people with extra body weight lose weight. It's for adults who are not diabetic and haven't used similar weight loss drugs before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
950 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are overweight or have excess body weight.
  • You do not have type 1 or type 2 diabetes.
  • Your HbA1c (blood sugar average over 3 months) is less than 6.5%.
  • You have not taken any GLP-1 or similar weight loss medications before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07861100Not yet recruiting· Phase 3
Heart disease and obesity weight-loss drug study

This study tests an investigational weight-loss medicine called Zenagamtide for people who have heart or blood vessel disease and are overweight or obese. The goal is to see if it can reduce heart-related risks compared to a placebo (a pill with no active medicine).

Birmingham, Alabama
NCT07770841Recruiting· Phase 3
Oral medication for weight loss study

This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.

Birmingham, Alabama
NCT07743450Recruiting· Phase 3
Daily oral medication for weight loss in adults with obesity and type 2 diabetes

This study tests a once-a-day pill for adults who are overweight or have obesity and also have type 2 diabetes. The goal is to see if the medication helps with weight loss and improves blood sugar control.

Birmingham, Alabama
NCT07668401Not yet recruiting· Phase 3
Weight loss study for adults in Asia

This study tests an investigational medicine called Zenagamtide to see if it helps people with excess body weight lose weight. It is specifically for adults in Asia who do not have diabetes and have not taken certain weight-loss or diabetes medicines before.

Surat, Gujarat
NCT07668414Recruiting· Phase 3
Study comparing Zenagamtide and Semaglutide for weight loss

This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.

Lancaster, California
NCT07815067Recruiting· Phase 1
Meal timing and water intake with Zenagamtide for overweight or obesity

This study tests how the timing of your meal and how much water you drink with the medicine affect how your body absorbs a new medicine called Zenagamtide. If you have overweight or obesity, this could help find the best way to take the medicine for maximum effect.

Berlin

Hear when a new Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.